Speaker illustration

Mrs Amber Van Broekhoven

Radboud University Nijmegen, Nijmegen (Netherlands (The))

Member of:

European Society of Cardiology

End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial.

Event: ESC Congress 2022

Topic: Prevention

Session: Coronary artery disease - Prevention

Thumbnail

This platform is supported by

logo Novo Nordisk